Rewiring Recovery: Advancing Nervous System Repair With NervGen’s Mike Kelly


In today’s episode, we discuss nervous system repair in the context of traumatic injury and disease with Mike Kelly, the President and CEO of NervGen. With more than three decades of pharmaceutical experience under his belt, Mike plays instrumental roles in the creation, development, and strengthening of a number of pharma companies. 

What’s his primary goal? To constantly innovate medical technology for people across the globe…

NervGen is a clinical-stage biotech company advancing innovative therapies for neurological recovery. Their lead drug candidate, NVG-291, is currently being evaluated in a Phase 1b/2a clinical trial for spinal cord injury. Additionally, they have launched preclinical studies for NVG-300 – a promising new development candidate, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS), and spinal cord injury.

Hit play to find out:

  • Where NervGen’s technology comes from.
  • What nervous system regeneration looks like at a molecular level. 
  • How clinical trials progress from animals to humans. 
  • The ways that biomarker results can indicate breakthroughs in science. 

Be sure to follow along with NerGen’s cutting-edge work by visiting their website!

Episode also available on Apple Podcast: http://apple.co/30PvU9C

Boost Your Brainpower with 15% OFF! 

Fuel your mind with BrainSupreme Supplements and unlock your full potential. Get 15% OFF your order now using this exclusive link: brainsupreme.co/discount/findinggenius

Hurry—your brain deserves the best!


Check out this episode!

Comments

Post a Comment

Popular posts from this blog

Anxiety Based Disorders, Cognitive Behavioral Therapy, and Distinguishing Fear and Anxiety with CBT Techniques with Catherine Pittman

What can we learn about our mental health from rats? Since our brains are similar, the answer may surprise you. Listen up to discover: The difference between fear and anxiety The pathways to anxiety and fear What a panic attack actually signals Catherine Pittman, an author and Professor of Psychology at St. Mary's College, shares her career developing cognitive behavioral therapy techniques dealing with fear and anxiety. By looking at how our brain may be similar to a rat's, we can begin to understand our fear responses and the effects they have. However, since it still triggers the amygdala, it can be challenging to control your body's response to stimuli. Since the cortex and amygdala are two of the important response centers in anxiety disorders, we must attempt to change how they learn. By presenting stimuli in a controlled setting with the help of cognitive behavioral therapies, relief can be brought to those who struggle with anxiety-based disorders. To learn...
Read more

Resetting Inflammation A Functional Medicine Approach With Dr. Josh Redd

Could chronic inflammation be the hidden driver behind many of today’s most common health issues even though many people don’t even realize it? In this episode, Dr. Josh Redd breaks down how inflammation develops, why it persists, and what you can do to finally address it at the root. Dr. Redd is the founder of RedRiver Health & Wellness and a leader in functional and personalized medicine. With over a decade of advanced training, his work combines deep expertise in human nutrition, immunology, and regenerative medicine. From helping patients rebalance their internal chemistry to performing precision-guided treatments for recovery and performance, his approach is both comprehensive and highly individualized. Hit play to discover: The root causes of chronic inflammation and how to identify them. Key blood markers that reveal what’s really happening in your body. How a 30-day reset can help rebalance your system. How regenerative medicine supports healing and recovery ...
Read more

Uncultivated Microbes: Dr. Samuel Miller On Anaerobes, Taxonomy, & The Future Of Microbiomics

In this episode, we sit down with Dr. Samuel Miller, Postdoctoral Research Associate and Senior Scientist at Oklahoma State University’s Elshahed Laboratory and Microbiomics and Culturomics Core Facility . A specialist in culturomics, Dr. Miller focuses on isolating and characterizing strict anaerobes and advancing microbial taxonomy and systematics. His current work zeroes in on gut-associated bacteria, using both cultivation-based and molecular approaches to investigate taxa that remain uncultivated in humans and other mammals. Hit play to learn about:  The key differences between anaerobic and aerobic bacteria. What happens to anaerobes when they are exposed to oxygen. How bacteria can be useful for humans. Ready to discover how Dr. Miller and the MCCF are advancing microbiome science and unlocking the mysteries of gut bacteria? Buckle in to dive inside the world of culturomics and anaerobes – where groundbreaking research is reshaping how we understand health, eco...
Read more